Skip to main content
. 2022 May 9;14(9):2335. doi: 10.3390/cancers14092335

Figure 1.

Figure 1

Figure 1

(A). Overall survival (OS) in HPV-, HPV+, and all patients according to body mass index (BMI), total lymphocyte count (TLC), hemoglobin (HB), and C-reactive protein (CRP) levels. (B). Overall survival (OS) in HPV-, HPV+, and all patients according to albumin and prealbumin levels and prognostic nutritional index (PNI).